Recently, Cui et al.1 revealed that neutrophil elastase (ELANE) can selectively kill a wide range of cancer cells while sparing proximal non-cancer cells and significantly attenuate tumorigenesis, suggesting a promising selective and broad anticancer strategy. Here, ELANE is linked to cancer.